What is the recommended dose of amoxicillin (amoxicillin-clavulanate) for a 150-pound female patient with community-acquired pneumonia and normal renal function?

Amoxicillin Dosing for Community-Acquired Pneumonia in a 150-pound Female

For a 150-pound (68 kg) female with community-acquired pneumonia and normal renal function, prescribe amoxicillin-clavulanate 875 mg/125 mg orally twice daily for 5-7 days, combined with either a macrolide or doxycycline 100 mg twice daily. 1

Outpatient Treatment Algorithm

Determine if the patient has comorbidities (chronic heart disease, lung disease, diabetes, renal disease, immunosuppression, or age ≥65 years). 1

For Otherwise Healthy Patients Without Comorbidities:

• High-dose amoxicillin 1 gram orally three times daily is the preferred first-line monotherapy 1, 2
• Amoxicillin-clavulanate is NOT recommended as monotherapy in this population 1
• Alternative: Doxycycline 100 mg twice daily (with 200 mg loading dose) 2

For Patients With Comorbidities (Most Common Scenario):

• Amoxicillin-clavulanate 875 mg/125 mg twice daily PLUS either azithromycin or doxycycline 100 mg twice daily 1, 3
• Alternative high-dose option: Amoxicillin-clavulanate 2000 mg/125 mg twice daily for areas with high rates of drug-resistant Streptococcus pneumoniae 4, 5
• Alternative monotherapy: Respiratory fluoroquinolone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) 1

Rationale for Combination Therapy

The combination regimen provides comprehensive coverage:

• Amoxicillin-clavulanate covers S. pneumoniae (including many penicillin-resistant strains), Haemophilus influenzae, and Moraxella catarrhalis 1, 6
• The macrolide or doxycycline adds coverage for atypical pathogens (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella species) 1, 2

Critical Dosing Details

Standard dosing for respiratory infections:

• Amoxicillin-clavulanate 875 mg/125 mg twice daily (preferred for better tolerability) 4
• OR 500 mg/125 mg three times daily 4
• Take at the start of meals to minimize gastrointestinal side effects and enhance clavulanate absorption 4

High-dose option for drug-resistant pneumococcus:

• Amoxicillin-clavulanate 2000 mg/125 mg twice daily covers S. pneumoniae with MICs up to 4 mg/L 5
• This formulation achieved 95.2% clinical success in patients with resistant strains 5

Treatment Duration

Treat for a minimum of 5 days and continue until the patient is afebrile for 48-72 hours with no more than one sign of clinical instability 1, 7

• Most uncomplicated cases: 5-7 days 7
• Meta-analysis of 2,796 patients showed no difference in clinical failure between short-course (≤7 days) and extended-course regimens 7

Important Caveats to Avoid Treatment Failure

Check for recent antibiotic exposure (within 3 months):

• If the patient recently received amoxicillin or a macrolide, select an alternative class (respiratory fluoroquinolone) to reduce resistance risk 1, 3

Assess for high local macrolide resistance:

• If local S. pneumoniae macrolide resistance exceeds 25%, avoid macrolide monotherapy 1
• Combination therapy with a beta-lactam remains appropriate 1

Do NOT substitute formulations:

• Two 250 mg/125 mg tablets ≠ one 500 mg/125 mg tablet (different clavulanate content) 4
• Always verify the correct strength is prescribed 4

Hospitalization criteria:

• If the patient meets severe CAP criteria (hypotension, respiratory distress, multilobar infiltrates, confusion), hospitalize and use IV therapy with ceftriaxone 1-2 g daily plus azithromycin or doxycycline 1

When Hospitalization is Required

For non-ICU hospitalized patients:

• IV ceftriaxone 1-2 g daily (or cefotaxime or ampicillin-sulbactam) PLUS azithromycin or doxycycline 100 mg IV/PO twice daily 1
• Switch to oral therapy when hemodynamically stable, improving clinically, and able to take oral medications 1

For ICU patients:

• IV beta-lactam (ceftriaxone, cefotaxime, or ampicillin-sulbactam) PLUS azithromycin (preferred) or respiratory fluoroquinolone 1
• Doxycycline is NOT recommended for severe CAP 2

Special Considerations for This Patient

For a 150-pound female specifically:

• Weight-based dosing is not required for adults; use standard adult dosing 4
• Consider pregnancy status before prescribing (doxycycline contraindicated in pregnancy; fluoroquinolones have warnings) 2
• If heart failure is present, avoid fluoroquinolone monotherapy due to arrhythmia risk 3